Citadel Advisors
PRCT icon

Citadel Advisors’s Procept Biorobotics PRCT Stock Holding History

Citadel Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-91,061
Closed -$2.57M – 13960
2025
Q4 		$2.86M Buy
91,061
+54,310
+148% +$1.8M ﹤0.01% 5257
2025
Q3 		$1.31M Buy
36,751
+28,765
+360% +$1.31M ﹤0.01% 6955
2025
Q2 		$460K Sell
7,986
-4,962
-38% -$281K ﹤0.01% 8832
2025
Q1 		$754K Sell
12,948
-61,230
-83% -$4.18M ﹤0.01% 7580
2024
Q4 		$5.97M Buy
74,178
+30,561
+70% +$2.61M ﹤0.01% 3682
2024
Q3 		$3.49M Buy
43,617
+16,217
+59% +$1.15M ﹤0.01% 4523
2024
Q2 		$1.67M Buy
27,400
+9,176
+50% +$546K ﹤0.01% 5652
2024
Q1 		$901K Sell
18,224
-237,483
-93% -$11.3M ﹤0.01% 7136
2023
Q4 		$10.7M Sell
255,707
-858,580
-77% -$29.2M ﹤0.01% 2748
2023
Q3 		$36.6M Buy
1,114,287
+638,676
+134% +$21.8M 0.01% 1337
2023
Q2 		$16.8M Sell
475,611
-494,029
-51% -$16.3M ﹤0.01% 2061
2023
Q1 		$27.5M Buy
969,640
+299,950
+45% +$10.6M 0.01% 1613
2022
Q4 		$27.8M Buy
669,690
+465,055
+227% +$20M 0.01% 1621
2022
Q3 		$8.48M Sell
204,635
-106,248
-34% -$4.24M ﹤0.01% 3005
2022
Q2 		$10.2M Buy
310,883
+127,881
+70% +$4.65M ﹤0.01% 2668
2022
Q1 		$6.4M Buy
183,002
+46,711
+34% +$1.12M ﹤0.01% 3708
2021
Q4 		$3.41M Buy
136,291
+113,439
+496% +$4.2M ﹤0.01% 5096
2021
Q3 		$872K Buy
+22,852
New +$877K ﹤0.01% 8492

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors's PRCT Position: Q1 2026 in Review

Citadel Advisors sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 91,061 shares — an estimated $2.57M sold.

Citadel Advisors first reported a position in PRCT in Q3 2021 and held it in 18 quarters. The position peaked at $36.6M in Q3 2023. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Citadel Advisors reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 91,061 Procept Biorobotics shares in Q1 2026, an estimated $2.57M.
  • Citadel Advisors first reported a position in Procept Biorobotics in Q3 2021 and held it in 18 quarters.
  • Citadel Advisors's Procept Biorobotics position peaked at $36.6M in Q3 2023.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.